NASDAQ$ICUI
ICU Medical Inc. · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
ICU Medical's first quarter results were generally in line with expectations, with revenue increasing compared to the same period last year and adjusted diluted earnings per share decreasing.
ICU Medical reported first quarter 2023 revenue of $568.6 million, a gross profit of $192.0 million, and a net loss of $(9.8) million, or $(0.41) per diluted share. Adjusted diluted earnings per share was $1.74, and adjusted EBITDA was $102.0 million.
- First quarter revenue was $568.6 million, compared to $543.1 million in the same period last year.
- GAAP gross profit for the first quarter was $192.0 million, compared to $168.8 million in the same period last year.
- GAAP net loss was $(9.8) million, or $(0.41) per diluted share, compared to $(38.1) million, or $(1.61) per diluted share, for the same period last year.
- Adjusted diluted earnings per share was $1.74, compared to $1.82 for the first quarter of 2022.
Headline financials
Revenue & EPS history
ICU Medical · Revenue · Quarterly
$569M
Revenue by segment
ICU Medical · $398M total across 2 segments · Q1 2023
- Consumables$236M+68.0%59.4%
- Infusion Systems$162M+85.9%40.6%
Forward guidance
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as ''will,'' ''expect,'' ''believe,'' ''could,'' ''would,'' ''estimate,'' ''continue,'' ''build,'' ''expand'' or the negative thereof or comparable terminology, and may include (without limitation) information regarding the Company's expectations, goals or intentions regarding the future.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
+0.3%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-0.3%
Avg return
30 days after
52%
38 / 73 earnings
Positive
+22.4%
Q2 2024
Best reaction
-33.3%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.8% | -0.8% | +10.7% | |
| Q4 2025 | +4.8% | +3.6% | -16.3% | |
| Q3 2025 | +8.2% | +7.3% | +9.9% | |
| Q1 2025 | -3.3% | -4.9% | -6.9% | |
| Q4 2024 | -2.3% | -4.1% | -6.4% | |
| Q3 2024 | -1.9% | -5.8% | -7.1% | |
| Q2 2024 | +22.4% | +19.7% | +31.2% | |
| Q1 2024 | -0.1% | +6.3% | +7.6% | |
| Q4 2023 | +6.5% | -0.2% | +1.6% | |
| Q3 2023 | -17.8% | -20.2% | -15.9% | |
| Q2 2023 | -15.2% | -15.6% | -16.8% | |
| Q1 2023 | +13.3% | +8.7% | +3.9% | |
| Q4 2022 | -3.6% | -4.2% | -7.3% | |
| Q3 2022 | +6.7% | +21.4% | +11.8% | |
| Q2 2022 | -7.4% | -4.7% | -8.0% | |
| Q1 2022 | -10.4% | -15.0% | -14.9% | |
| Q4 2021 | +5.8% | +9.0% | +4.3% | |
| Q3 2021 | +2.1% | +2.7% | -6.4% | |
| Q2 2021 | +0.7% | +1.2% | +6.1% | |
| Q1 2021 | -5.0% | -6.5% | -2.1% | |
| Q4 2020 | -5.5% | -6.8% | -4.4% | |
| Q3 2020 | +0.6% | +4.8% | +5.6% | |
| Q2 2020 | +8.8% | +5.0% | +9.8% | |
| Q1 2020 | -8.8% | -13.7% | -8.0% | |
| Q4 2019 | -4.2% | -4.8% | -8.2% | |
| Q3 2019 | +6.9% | +4.3% | +6.8% | |
| Q2 2019 | -33.3% | -31.2% | -36.6% | |
| Q1 2019 | -2.7% | -3.3% | -2.2% | |
| Q4 2018 | +2.5% | -4.9% | -2.8% | |
| Q3 2018 | -10.6% | -14.8% | -10.6% | |
| Q2 2018 | +2.2% | +2.4% | +3.7% | |
| Q1 2018 | +1.4% | +4.3% | +12.4% | |
| Q4 2017 | +4.6% | +7.5% | +9.1% | |
| Q3 2017 | +8.6% | +10.1% | +11.7% | |
| Q2 2017 | -2.9% | -2.4% | +3.4% | |
| Q1 2017 | -0.2% | -0.1% | +6.2% | |
| Q4 2016 | +0.7% | -1.0% | +1.5% | |
| Q3 2016 | -0.4% | -0.9% | +2.5% | |
| Q2 2016 | +7.5% | +6.1% | +8.6% | |
| Q1 2016 | -1.0% | — | — | |
| Q4 2015 | -8.7% | — | — | |
| Q3 2015 | +5.8% | — | — | |
| Q2 2015 | +19.9% | — | — | |
| Q1 2015 | +7.3% | — | — | |
| Q4 2014 | +2.2% | — | — | |
| Q3 2014 | +13.6% | — | — | |
| Q2 2014 | +10.5% | — | — | |
| Q1 2014 | +3.3% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | +3.0% | — | — | |
| Q2 2013 | -6.7% | — | — | |
| Q1 2013 | +1.3% | — | — | |
| Q4 2012 | +1.1% | — | — | |
| Q3 2012 | +3.7% | — | — | |
| Q2 2012 | -0.2% | — | — | |
| Q1 2012 | +0.8% | — | — | |
| Q4 2011 | +1.9% | — | — | |
| Q3 2011 | +0.2% | — | — | |
| Q2 2011 | -3.9% | — | — | |
| Q1 2011 | +2.2% | — | — | |
| Q4 2010 | +0.1% | — | — | |
| Q3 2010 | -0.9% | — | — | |
| Q2 2010 | +3.4% | — | — | |
| Q1 2010 | -1.0% | — | — | |
| Q4 2007 | -1.0% | — | — | |
| Q4 2009 | -1.0% | — | — | |
| Q3 2009 | -0.8% | — | — | |
| Q3 2008 | -0.8% | — | — | |
| Q2 2009 | -0.6% | — | — | |
| Q2 2008 | -3.9% | — | — | |
| Q1 2009 | -3.9% | — | — | |
| Q4 2008 | -3.9% | — | — | |
| Q1 2008 | -3.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro